| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
2
2
1
1
2
|
|
Zacks Investment Research
4
(Sell)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
D-
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 2.83 | 2.49 | 0.33 |
| Stocks | 0.0 | 0.0 | 0.0 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.02 | 0.0 | 0.02 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 99.63 | 0.0 | 99.63 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.02 | 0.0 | 0.02 |
Updated 04.30.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 04.30.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Roche Holding AG | RHHVF | 21.67 | 3.43 |
| Anheuser-Busch Inbev SA | AHBIF | 7.6 | 3.3 |
| Sanofi | SAN | --- | 3.18 |
| Novo Nordisk A/S | NONOF | 1.46 | 3.15 |
| Nestle SA | NSRGF | 0.68 | 3.08 |
| L'Oreal SA | OR | --- | 2.9 |
| Barclays PLC | BCLYF | 14.74 | 2.81 |
| Vodafone Group PLC | VODPF | 15.32 | 2.74 |
| Sap AG | SAP | --- | 2.62 |
| UBS AG | UBS | 14.67 | 2.44 |
